Pharmacokinetics of brain natriuretic peptide in rats.

Effects of brain natriuretic peptide-45, a circulating form of rat brain natriuretic peptide, in spontaneously hypertensive rats.

Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide.

Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.

C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain.

Human brain natriuretic peptide-like immunoreactivity in human brain.

Brain natriuretic peptide among stroke patients.

Brain natriuretic peptide and C-type natriuretic peptide maintain porcine oocyte meiotic arrest.

Brain natriuretic peptide is cosecreted with atrial natriuretic peptide from porcine cardiocytes.

Arginine vasopressin V1-antagonist and atrial natriuretic peptide reduce hemorrhagic brain edema in rats.

Utility of point-of-care testing of natriuretic peptides (brain natriuretic peptide and n-terminal pro-brain natriuretic peptide) in the emergency department.

Characterization of immunoreactive brain natriuretic peptide in human cardiac atrium.

Augmented secretion of brain natriuretic peptide in acute myocardial infarction.

Increased secretion of brain natriuretic peptide and atrial natriuretic peptide, but not sufficient to induce natriuresis in rats with nephrotic syndrome.

Structure-activity studies on the effects of atrial natriuretic peptide, brain natriuretic peptide and their analogs on fear-motivated learning behavior in rats.

C-type natriuretic peptide (CNP) in rats and humans.

B-type (brain) natriuretic peptide and pruritus in hemodialysis patients.

Increased human brain natriuretic peptide in congestive heart failure.

Serum brain natriuretic peptide in children with Kawasaki disease.

Brain natriuretic peptide as a cardiac hormone in essential hypertension.

Antiserum against homologous atrial natriuretic peptide diminishes the natriuretic response during mineralocorticoid escape in rats.

Atrial and brain natriuretic peptides: a dual natriuretic peptide system potentially involved in circulatory homeostasis.

Plasma mid-regional pro-atrial natriuretic peptide and N-terminal pro-brain natriuretic peptide improve discrimination of lone atrial fibrillation.

Biological effects of rat iso-atrial natriuretic peptide and brain natriuretic peptide are indistinguishable from each other.

The relationship among brain natriuretic peptide (BNP), cholesterol and lipoprotein.

Suggest Documents

Effects of brain natriuretic peptide-45, a circulating form of rat brain natriuretic peptide, in spontaneously hypertensive rats.

Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide.

Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.

C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain.

Human brain natriuretic peptide-like immunoreactivity in human brain.

Brain natriuretic peptide among stroke patients.

Brain natriuretic peptide and C-type natriuretic peptide maintain porcine oocyte meiotic arrest.

Brain natriuretic peptide is cosecreted with atrial natriuretic peptide from porcine cardiocytes.

Arginine vasopressin V1-antagonist and atrial natriuretic peptide reduce hemorrhagic brain edema in rats.

Utility of point-of-care testing of natriuretic peptides (brain natriuretic peptide and n-terminal pro-brain natriuretic peptide) in the emergency department.

Characterization of immunoreactive brain natriuretic peptide in human cardiac atrium.

Augmented secretion of brain natriuretic peptide in acute myocardial infarction.

Increased secretion of brain natriuretic peptide and atrial natriuretic peptide, but not sufficient to induce natriuresis in rats with nephrotic syndrome.

Structure-activity studies on the effects of atrial natriuretic peptide, brain natriuretic peptide and their analogs on fear-motivated learning behavior in rats.

C-type natriuretic peptide (CNP) in rats and humans.

B-type (brain) natriuretic peptide and pruritus in hemodialysis patients.

Increased human brain natriuretic peptide in congestive heart failure.

Serum brain natriuretic peptide in children with Kawasaki disease.

Brain natriuretic peptide as a cardiac hormone in essential hypertension.

Antiserum against homologous atrial natriuretic peptide diminishes the natriuretic response during mineralocorticoid escape in rats.

Atrial and brain natriuretic peptides: a dual natriuretic peptide system potentially involved in circulatory homeostasis.

Plasma mid-regional pro-atrial natriuretic peptide and N-terminal pro-brain natriuretic peptide improve discrimination of lone atrial fibrillation.

Biological effects of rat iso-atrial natriuretic peptide and brain natriuretic peptide are indistinguishable from each other.

The relationship among brain natriuretic peptide (BNP), cholesterol and lipoprotein.

Pharmacokinetics of brain natriuretic peptide in rats.

Recommend Documents

Follow Us